California Public Employees Retirement System Kymera Therapeutics, Inc. Transaction History

California Public Employees Retirement System

$141 Billion
Q3 2024

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$31.08 - $51.95 $553,224 - $924,710	-17,800 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$35.64 - $85.46 $58,342 - $139,898	-1,637 Reduced 8.42%	17,800 $692,000
Q4 2020 Feb 02, 2021	SELL	$28.07 - $87.83 $11,228 - $35,132	-400 Reduced 2.02%	19,437 $1.21 Million
Q3 2020 Nov 05, 2020	BUY	$26.1 - $33.28 $517,745 - $660,175	19,837 New	19,837 $641,000

Others Institutions Holding KYMR

# of Institutions

183

Shares Held

64.4M

Call Options Held

50.6K

Put Options Held

81.7K

Price T Rowe Associates Inc Baltimore, MD

6.65M
Shares

$259 Million
0.04% of portfolio
Baker Bros. Advisors LP New York, NY

6M
Shares

$234 Million
3.04% of portfolio
Bvf Inc San Francisco, CA

5.16M
Shares

$202 Million
7.77% of portfolio
Atlas Venture Life Science Advisors, LLC

4.9M
Shares

$191 Million
32.49% of portfolio
Vanguard Group Inc Valley Forge, PA

4.75M
Shares

$186 Million
0.0% of portfolio

View Full List

About Kymera Therapeutics, Inc.

Ticker KYMR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,705,800
Market Cap $2.14B
Description
Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...

More about KYMR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.

Account